VYTRO

2024

1. A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis

   Cancers, Vol. 16, Núm. 9

2. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

   Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

3. Analysis of the prognostic value of emergency blood tests in ischaemic stroke

   Neurologia, Vol. 39, Núm. 8, pp. 617-628

4. Biomarcadores de estrés oxidativo e inflamación en lesión renal aguda postcontraste yodado

   Anales del sistema sanitario de Navarra, Vol. 47, Núm. 2, pp. 47-58

5. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

   Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

6. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

7. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 10, pp. 2910-2921

8. Diagnostic and Prognostic Potential of Multiparametric Renal MRI in Kidney Transplant Patients

   Journal of Magnetic Resonance Imaging

9. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

   Neurologia

10. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

    Blood, Vol. 144, Núm. 8, pp. 873-887

11. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

12. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

    Frontiers in Neurology , Vol. 15

13. Estándares de la Sociedad Española de Arteriosclerosis 2024 para el control global del riesgo vascular

    Clínica e investigación en arteriosclerosis, Vol. 36, Núm. 3, pp. 133-194

14. Factor XI inhibitors: A new era in antithrombotic therapy

    Medicina Clinica

15. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review

    European Journal of Neurology, Vol. 31, Núm. 6

16. Immunothrombosis: A key mechanism in the COVID-19 pandemic

    Medicina Clinica

17. Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

    Journal of Headache and Pain, Vol. 25, Núm. 1

18. Is tranexamic acid appropriate for all patients undergoing high-risk surgery?

    Current Opinion in Critical Care

19. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study

    Frontiers in Neurology , Vol. 15

20. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment

    Medicina Clinica, Vol. 163, Núm. 4, pp. 208.e1-208.e10